-
公开(公告)号:US10738037B2
公开(公告)日:2020-08-11
申请号:US16301826
申请日:2017-05-18
IPC分类号: C07D405/12 , C07D405/14 , A61P35/00
摘要: The present invention relates to a new crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide, process for its preparation, its utility in treating diseases caused by deregulated protein kinase activity and pharmaceutical compositions containing it.
-
公开(公告)号:US11091469B2
公开(公告)日:2021-08-17
申请号:US16912965
申请日:2020-06-26
IPC分类号: C07D405/12 , C07D405/14 , A61P35/00
摘要: The present invention relates to a new crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide, process for its preparation, its utility in treating diseases caused by deregulated protein kinase activity and pharmaceutical compositions containing it.
-